Founders Capital Management (Texas)’s Allergan plc AGN Stock Holding History

Founders Capital Management (Texas)’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-276	Closed	-$46K	–	307
2020 Q4	$46K	Buy	+276	New	+$46K	0.03%	112
2020 Q1	$70K	Buy	414 +138	+50%	+$26K	0.07%	73
2019 Q4	$53K	Hold	276	–	–	0.04%	102
2019 Q3	$46K	Hold	276	–	–	0.04%	112
2019 Q2	$46K	Hold	276	–	–	0.04%	118
2019 Q1	$40K	Hold	276	–	–	0.04%	129
2018 Q4	$37K	Hold	276	–	–	0.04%	128
2018 Q3	$53K	Hold	276	–	–	0.04%	113
2018 Q2	$46K	Hold	276	–	–	0.04%	122
2018 Q1	$46K	Hold	276	–	–	0.04%	143
2017 Q4	$45K	Hold	276	–	–	0.04%	145
2017 Q3	$57K	Hold	276	–	–	0.05%	128
2017 Q2	$67K	Hold	276	–	–	0.06%	122
2017 Q1	$66K	Buy	+276	New	+$64.3K	0.06%	126

Other funds holding AGN

ABC

Associated Banc-Corp Green Bay, Wisconsin $4.21B AUM 27.98% 1-Year Est. Return

Founders Capital Management (Texas)'s AGN Position: Q1 2021 in Review

Founders Capital Management (Texas) sold out of Allergan plc (AGN) in Q1 2021, closing a stake of 276 shares — an estimated $46K sold.

Founders Capital Management (Texas) first reported a position in AGN in Q1 2017 and held it in 14 quarters. The position peaked at $70K in Q1 2020. 2 funds tracked by Wall St. Rank hold AGN as of Q1 2021.

Founders Capital Management (Texas) reported no remaining Allergan plc position as of Q1 2021 after selling out during the quarter.
Founders Capital Management (Texas) sold 276 Allergan plc shares in Q1 2021, an estimated $46K.
Founders Capital Management (Texas) first reported a position in Allergan plc in Q1 2017 and held it in 14 quarters.
Founders Capital Management (Texas)'s Allergan plc position peaked at $70K in Q1 2020.
2 funds tracked by Wall St. Rank held Allergan plc as of Q1 2021.

Based on Founders Capital Management (Texas)'s 13F filing for Q1 2021, filed 7 Jun 2021.